NVS

Novartis
D

NVS

Arincen80/100B

Novartis earnings

Novartis reports its Q4 FY2026 results on 3 February 2027, before the market opens. Analysts expect earnings per share of 2.23 USD and revenue of 14.65B USD.

In Q3 FY2026, reported on 27 October 2026, Novartis earned 2.46 USD a share against the 2.25 USD analysts expected (+9.3%), on revenue of 14.52B USD against 14.53B USD (-0.1%).

Last EPS surprise
+9.3%
Last revenue surprise
-0.1%
Move after the last report
+2.0%
Average move after earnings
2.1%

EPS and revenue against estimates

Next earnings · Q4 FY2026
EPS estimate
2.23 USD
Revenue estimate
14.65B USD
Last quarter · Q3 FY2026
EPS2.46Beat +9.3%Revenue14.52BMissed -0.1%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growthNext-day move
Q4 FY20262.23——+9.85%14.65B——+9.83%—
Q3 FY20262.252.46+9.33%+9.33%14.53B14.52B-0.07%+1.14%+2.0%
Q2 FY20262.172.41+11.06%-0.41%14.07B14.41B+2.43%+0.90%+2.9%
Q1 FY20262.111.99-5.69%-12.72%13.44B13.11B-2.42%-3.72%+0.9%
Q4 FY20251.992.03+2.01%+2.53%13.70B13.34B-2.69%-1.64%+2.1%
Q3 FY20252.262.25-0.44%+9.22%13.64B14.36B+5.25%+9.00%-4.3%
Q2 FY20252.382.42+1.68%+22.84%13.94B14.28B+2.47%+14.13%-3.3%
Q1 FY20252.122.28+7.55%+26.67%13.90B13.62B-2.01%+15.14%+0.7%
Q4 FY20241.801.98+10.00%+29.41%12.84B13.56B+5.61%+15.13%-0.1%
Q3 FY20241.942.06+6.19%+18.39%12.76B13.17B+3.20%+8.93%-4.4%
Q2 FY20241.891.97+4.23%+7.65%12.54B12.51B-0.23%-10.22%-4.1%
Q1 FY20241.731.80+4.05%+5.26%11.44B11.83B+3.40%-10.44%+2.3%
Q4 FY20231.641.53-6.71%+1.32%11.88B11.78B-0.91%-10.02%-4.0%
Q3 FY20231.701.74+2.35%+10.13%12.42B12.09B-2.61%-5.84%+0.2%
Q2 FY20231.681.83+8.93%+17.31%13.47B13.94B+3.43%+6.50%+4.6%
Q1 FY20231.551.71+10.32%+17.12%12.72B13.21B+3.86%+3.07%+3.4%
Q4 FY20221.421.51+6.34%+7.86%13.22B13.09B-1.00%-3.22%-2.6%
Q3 FY20221.571.58+0.64%-7.60%12.88B12.84B-0.33%-3.93%+0.9%
Q2 FY20221.511.56+3.31%-6.02%12.88B13.09B+1.59%-1.57%+4.0%
Q1 FY20221.441.46+1.39%-3.95%12.62B12.81B+1.55%+0.95%-1.6%
Q4 FY20211.441.40-2.78%+4.48%13.33B13.52B+1.46%+3.78%-2.6%
Q3 FY20211.651.71+3.64%+12.50%12.95B13.37B+3.21%+6.61%+1.8%
Q2 FY20211.531.66+8.50%+22.96%12.95B13.29B+2.64%+14.39%+0.2%
Q1 FY20211.571.52-3.18%-1.94%13.25B12.69B-4.22%-0.11%-1.4%
Q4 FY20201.381.34-2.90%+2.29%13.22B13.03B-1.45%+2.47%-2.6%
Q3 FY20201.421.52+7.04%+7.80%11.93B12.54B+5.07%+0.45%-3.9%
Q2 FY20201.291.35+4.65%+2.27%11.18B11.62B+3.97%-3.34%-2.3%
Q1 FY20201.371.55+13.14%+29.17%10.95B12.71B+16.10%+10.94%-1.9%
Q4 FY20191.321.31-0.76%+5.65%12.42B12.72B+2.38%-6.94%+0.2%
Q3 FY20191.311.41+7.63%+7.63%12.02B12.48B+3.82%+9.63%+0.5%
Q2 FY20191.201.32+10.00%+4.76%10.84B12.02B+10.91%-10.62%+4.5%
Q1 FY20191.111.20+8.11%-6.25%10.96B11.46B+4.50%-11.40%+2.6%
Q4 FY20181.331.24-6.77%+3.33%13.98B13.66B-2.29%+3.80%-1.1%
Q3 FY20181.311.310.00%+1.55%11.21B11.39B+1.56%-10.29%+1.0%
Q2 FY20181.271.26-0.79%+4.13%13.24B13.45B+1.60%+7.67%+2.8%
Q1 FY20181.251.28+2.40%+13.27%12.93B12.93B0.00%+9.71%-3.3%
Q4 FY20171.161.20+3.45%+7.14%12.94B13.16B+1.71%+4.43%+4.9%
Q3 FY20171.251.29+3.20%+4.88%12.29B12.69B+3.31%+2.84%-3.3%
Q2 FY20171.161.21+4.31%-0.82%12.28B12.49B+1.71%-1.46%+1.7%
Q1 FY20171.101.13+2.73%-3.42%11.57B11.79B+1.83%-0.21%+2.2%
Q4 FY20161.091.12+2.75%+0.90%12.61B12.61B0.00%-1.55%+3.0%
Q3 FY20161.181.23+4.24%-3.15%11.93B12.34B+3.48%-1.15%-3.7%
Q2 FY20161.181.22+3.39%-3.17%12.14B12.68B+4.42%-1.68%-0.6%
Q1 FY20161.181.17-0.85%-12.03%12.01B11.81B-1.67%-3.21%-0.4%
Q4 FY20151.221.11-9.02%-8.26%13.78B12.80B-7.09%-4.12%-5.4%
Q3 FY20151.311.27-3.05%-7.30%12.87B12.49B-2.96%-6.13%-2.3%
Q2 FY20151.201.26+5.00%-5.97%12.79B12.90B+0.81%-7.55%-2.3%
Q1 FY20151.121.33+18.75%+3.91%10.09B12.20B+20.88%-14.31%+2.0%
Q4 FY20141.131.21+7.08%+0.83%13.35B13.35B0.00%-13.08%+2.5%
Q3 FY20141.291.37+6.20%+9.60%12.48B13.30B+6.61%-8.64%+2.4%
Q2 FY20141.401.34-4.29%+3.08%14.55B13.95B-4.11%-5.13%-1.7%
Q1 FY20141.331.28-3.76%-1.54%14.77B14.24B-3.62%+0.23%-1.8%
Q4 FY20131.221.20-1.64%-5.51%16.22B15.36B-5.26%+1.96%-0.4%
Q3 FY20131.321.25-5.30%-6.72%15.22B14.56B-4.38%+3.70%+3.3%
Q2 FY20131.291.30+0.78%-5.80%14.82B14.70B-0.77%+1.12%-0.8%
Q1 FY20131.251.30+4.00%+2.36%13.76B14.21B+3.23%+2.11%-1.0%
Q4 FY20121.271.270.00%+3.25%14.06B15.07B+7.21%+0.48%+3.4%
Q3 FY20121.381.34-2.90%-7.59%14.25B14.04B-1.45%-6.62%-0.4%
Q2 FY20121.291.38+6.98%-6.76%13.53B14.54B+7.50%-3.85%+1.8%
Q1 FY20121.321.27-3.79%-9.93%14.44B13.91B-3.65%-2.17%-1.4%
Q4 FY20111.201.23+2.50%+7.89%14.62B15.00B+2.56%+3.68%-1.2%
Q3 FY20111.511.45-3.97%+14.17%15.63B15.03B-3.82%+17.27%-4.2%
Q2 FY20111.401.48+5.71%+23.33%14.26B15.12B+6.06%+26.86%+2.2%
Q1 FY20111.311.41+7.63%-2.08%13.14B14.22B+8.26%+15.10%+3.7%
Q4 FY20101.251.14-8.80%+12.87%15.74B14.46B-8.09%+10.03%-2.9%
Q3 FY20101.201.27+5.83%+38.04%12.07B12.82B+6.19%+13.55%-0.9%
Q2 FY20101.131.20+6.19%+34.83%11.18B11.92B+6.60%+10.98%+0.9%
Q1 FY20101.231.44+17.07%+65.52%10.25B12.36B+20.59%+24.48%+0.1%
Q4 FY20091.101.01-8.18%+53.03%14.22B13.15B-7.56%+27.03%+1.7%
Q3 FY20090.950.92-3.16%0.00%11.65B11.29B-3.06%+2.36%+1.0%
Q2 FY20090.850.89+4.71%-9.18%10.24B10.74B+4.94%+0.15%+2.6%
Q1 FY20090.870.870.00%-14.71%9.93B9.93B0.00%-2.84%+3.8%
Q4 FY20080.790.66-16.46%+65.00%12.05B10.35B-14.13%+1.74%-5.1%
Q3 FY20080.950.92-3.16%+35.29%11.38B11.03B-3.06%+12.34%+2.4%
Q2 FY20080.930.98+5.38%+18.07%10.15B10.73B+5.68%+14.11%+1.5%
Q1 FY20080.891.02+14.61%+10.87%8.72B10.22B+17.11%+4.05%+3.4%
Q4 FY20070.730.40-45.21%-42.86%13.29B10.17B-23.48%+9.14%-4.2%
Q3 FY20070.760.68-10.53%-13.92%10.85B9.82B-9.52%+1.32%+0.8%
Q2 FY20070.780.83+6.41%+13.70%8.80B9.40B+6.85%+2.37%-2.4%
Q1 FY20070.840.92+9.52%+10.84%8.88B9.82B+10.53%+18.27%-0.7%
Q4 FY20060.780.70-10.26%+20.69%10.27B9.32B-9.30%+6.47%-2.5%
Q3 FY20060.760.79+3.95%+11.27%9.31B9.69B+4.11%+14.15%+3.8%
Q2 FY20060.790.73-7.59%+3.69%9.88B9.18B-7.06%+16.67%+0.1%
Q1 FY20060.710.83+16.90%—6.90B8.30B+20.34%—+0.3%
Q4 FY20050.710.58-18.31%+3.57%10.36B8.75B-15.48%+15.51%-1.6%
Q3 FY20050.720.71-1.39%+12.70%8.61B8.49B-1.37%+20.29%+3.7%
Q2 FY20050.660.70+6.06%+11.11%7.39B7.34B-0.70%+5.28%+2.3%
Q2 FY2005—0.70—+11.75%—7.87B—+12.86%-0.2%
Q4 FY20040.600.56-6.67%+1.82%8.08B7.58B-6.25%+12.60%-1.3%
Q3 FY20040.580.63+8.62%+21.15%6.45B7.06B+9.43%+13.64%+1.1%
Q2 FY20040.590.63+6.78%+21.15%6.50B6.97B+7.27%+12.41%+5.6%
Q1 FY20040.530.52-1.89%+20.93%6.76B6.64B-1.85%+16.05%-2.0%
Q4 FY20030.530.55+3.77%+22.22%6.48B6.73B+3.92%-13.77%+0.1%
Q3 FY20030.520.520.00%+18.32%6.21B6.21B0.00%+22.75%+1.7%
Q2 FY20030.510.52+1.96%—6.08B6.20B+2.00%—-1.3%
Q1 FY20030.460.43-6.52%—6.09B5.72B-6.12%—+2.7%
Q4 FY20020.420.45+7.14%+11.50%—7.81B—+51.91%+0.8%
Q3 FY20020.440.55+24.32%+24.89%—5.60B—+0.39%-2.8%
Q3 FY2002—0.44—+0.34%—5.06B—-9.27%+0.7%
Q4 FY2001—0.43—+4.02%—4.86B—+9.41%+0.1%
Q4 FY2001—0.40—-2.37%—5.14B—+15.72%+0.3%
Q3 FY2001—0.44—+32.73%—5.58B—+14.24%-0.0%
Q2 FY2001—0.40—-18.07%—4.31B—-25.75%-0.4%
Q1 FY2001—0.41———5.96B——-0.7%
Q4 FY2000—0.41—-15.63%—4.44B—-22.06%-1.3%
Q3 FY2000—0.33———4.88B——+0.5%
Q2 FY2000—0.49———5.81B——+1.6%
Q4 FY1999—0.49———5.70B——+3.6%
Q4 FY19970.560.51-8.93%—————-2.0%
Q2 FY19970.790.790.00%—————+2.7%
Q1 FY19970.450.52+15.56%—————+0.2%

The move is the shares' change on the trading day after the report: after a report after the close, the next day's close on the report day's; before the open, the report day's close on the day before's. Surprise is the reported figure against the analysts' average estimate.

Q4 FY2026

What the market is waiting for

From the last earnings call, the company's guidance and analysts' previews, and checked against the report when it comes.

High importanceWaiting for 3 Feb

Sales outlook

Expected2027 revenue guidance of about $59.4 billionanalysts
The resultComes with the report on 3 Feb

The outlook will show how quickly Novartis expects drug sales to recover from generic competition.

Beat record

On average, analysts' EPS estimate was 5.7% off the result, either way, and their revenue estimate 2.6%, over the last 12 quarters.

EPS beats
60 / 99
Revenue beats
51 / 94
Average EPS surprise, last 12
+3.6%
Since
April 1997

See also:Forecast,EPS,Income statement

Common questions about Novartis's earnings

Source: Financial Modeling Prep